von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy.
Rutter K, Etschmaier A, Ferlitsch M, Maieron A, Hametner S, Horvatits T, Paternostro R, Salzl P, Reiberger T, Peck-Radosavljevic M, Quehenberger P, Hofer H, Trauner M, Ferenci P, Ferlitsch A.
Rutter K, et al. Among authors: reiberger t.
Dig Liver Dis. 2016 Oct;48(10):1194-9. doi: 10.1016/j.dld.2016.06.033. Epub 2016 Jul 19.
Dig Liver Dis. 2016.
PMID: 27476467